Therapeutic Potential and Strategies for Inhibiting Tumor Necrosis Factor-α
- 1 July 1999
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 42 (13) , 2295-2314
- https://doi.org/10.1021/jm980541n
Abstract
No abstract availableThis publication has 162 references indexed in Scilit:
- 7-Oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridines as Novel Inhibitors of Human Eosinophil PhosphodiesteraseJournal of Medicinal Chemistry, 1998
- hUBC9 associates with MEKK1 and type I TNF‐α receptor and stimulates NFκB activityFEBS Letters, 1998
- TRAF2 plays a dual role in NF‐κB‐dependent gene activation by mediating the TNF‐induced activation of p38 MAPK and IκB kinase pathwaysFEBS Letters, 1998
- Role of an acidic compartment in tumor‐necrosis‐factor‐α−induced production of ceramide, activation of caspase‐3 and apoptosisEuropean Journal of Biochemistry, 1998
- Purification of ADAM 10 from bovine spleen as a TNFα convertaseFEBS Letters, 1997
- Map of the human MHCImmunology Today, 1993
- Pyridinyl imidazoles inhibit IL-1 and TNF production at the protein levelInflammation Research, 1993
- Structural analysis of the rabbit TNF locus, containing the genes encoding TNF-β(lymphotoxin) and TNF-α(tumor necrosis factor)Gene, 1990
- Detection of Circulating Tumor Necrosis Factor after Endotoxin AdministrationNew England Journal of Medicine, 1988
- Tumour necrosis factor is a compact trimerFEBS Letters, 1987